Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004336:Drug Antagonism; D005260:Female; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects*; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008168:Lung / Q000187:drug effects*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D011651:Pulmonary Artery; D011652:Pulmonary Circulation; D011955:Receptors, Drug / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D011955:Receptors, Drug; D013565:Sympatholytics; D005934:Glucagon; D011433:Propranolol; D007545:Isoproterenol